Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

BISACODYL DELAYED-RELEASE TABLETS

Awarded
SPE2DP26F7668Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded a single-line delivery order to DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7668 for the supply of 4.000 boxes of BISACODYL DELAYED-RELEASE TABLETS, with a total contract value of $4.32. The award was issued on July 14, 2026, and the delivery is scheduled for July 29, 2026, under the parent contract SPE2DX25D9900. The product is identified by NSN 6505001182759 and NDC 00904-6407-61, with the manufacturer’s CAGE code listed as 1LEZO and the awardee’s CAGE code as 1UNB0. Delivery is to be made FOB destination to Fort Stewart, Georgia, with the contractor bearing all transportation costs and risks until final acceptance at the delivery point. Inspection and acceptance occur at the destination, and parcel post is strictly prohibited; shipments must be sent via traceable means. Each shipment must include the traceable control number W33RBS61940139 and be properly labeled with the designated delivery address. The contract is coded under NAICS 424210, falls under federal procurement, and uses a firm-fixed-price structure, though no formal FAR or DFARS clauses are explicitly listed in the provided documentation. Payment responsibility rests with the contractor, and no specific invoicing system, contracting officer contact, or evaluation factors are detailed. The acquisition is not designated with any socioeconomic set-aside, and no representations, certifications, or special requirements such as security clearances or subcontracting plans are indicated. Packaging, marking, and bar-coding requirements are minimal and based on contract-specific directives rather than MIL-STD standards. Accounting and appropriation data is limited to a DIC code A0A, PR 7017499838, and a SUPP ADD code W9046W, with no explicit TAS or AAC identifiers provided. The entire transaction is a low-value, single-delivery procurement executed as a streamlined supply order without supplemental clauses or formal compliance documentation typically associated with more complex contracts.

General Info

DMS PHARMACEUTICAL GROUP INC awarded $4.32 for bisacodyl tablets under DLA contract SPE2DP26F7668.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

Contract Value

$4.32

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INCView Profile

Award Issued Date

Documents

(2)

SPE2DP26F7668.pdf

PDF

SPE2DP26F7668.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7668 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $4.32 Award Date: 07-14-2026 Delivery order under: SPE2DX25D9900 Line items: - BISACODYL DELAYED-RELEASE TABLETS (NSN/Part 6505001182759, PR 7017499838)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-26-T-4988
Solicitation SPE2DP-26-T-4988 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon-flavored electrolyte oral rehydration powder. The requirement is for three packages, with each package containing 100 packets of 21 grams each. Each packet is formulated to provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when dissolved in 16.9 fluid ounces of solution. The specified product is Drip Drop Hydration Inc. part number 61406 under NSN 6505-01-646-2692, and it must have a non-extendable shelf life of 24 months. Delivery is required within 20 days of award, with a required delivery date of September 9, 2026. The shipment is FOB Destination to the USS Tucson (SSN 770) at FPO AP 96679. Inspection and acceptance will also occur at the destination. Packaging must be commercial and compliant with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951, unless the material is deemed hazardous per FED-STD-313, in which case TQ requirement IP025 applies. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The award process may be automated, and the contract incorporates various federal regulations, including the Buy American Act, Berry Amendment, and DFARS cybersecurity standards for safeguarding covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS